Europe mRNA Synthesis & Manufacturing Market (2024-2029)
The Europe mRNA Synthesis & Manufacturing Market was valued at $359.36 Million in 2024 and projected to reach to $445.49 Million by 2029, representing a compound annual growth rate of 4.4%. Europe's mRNA synthesis and manufacturing market is positioned for steady expansion through 2029, supported by increasing investments in biopharmaceutical infrastructure and growing demand for mRNA-based therapeutics.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Europe mRNA Synthesis & Manufacturing Market Trends and Insights
- Europe has emerged as a critical hub for mRNA technology development and production, driven by strong regulatory frameworks, established pharmaceutical infrastructure, and significant investment in biotechnology innovation.
- The region's commitment to advancing mRNA therapeutics and vaccines positions Europe as a key player in the global market. The growth trajectory in Europe reflects increasing demand for mRNA-based therapeutics, vaccine manufacturing capacity expansion, and collaborative partnerships between academic institutions and industry players.
- Europe's regulatory bodies, including the European Medicines Agency (EMA), have streamlined approval pathways for mRNA products, accelerating market entry and commercialization.
- Between 2024 and 2029, Europe is expected to benefit from rising healthcare expenditures, government support for biopharmaceutical manufacturing, and growing clinical applications beyond infectious diseases. Key European markets, including Germany, Switzerland, and the United Kingdom, are driving innovation in mRNA synthesis platforms and contract manufacturing services.
- Europe's focus on supply chain resilience and domestic production capacity strengthens its competitive position in the global mRNA synthesis and manufacturing landscape..
Key Market Statistics
- CAGR (2024-2029) 4.4% CAGR
- Market Size, 2024 ~USD 359.36 Million
- Forecast, 2029 ~USD 445.49 Million
- Geography Europe
Europe mRNA Synthesis & Manufacturing Market Overview
Market Leadership Position :
Europe commands a significant share of the global mRNA synthesis and manufacturing market, valued at $359.36 million in 2024, establishing itself as a critical hub for mRNA technology development and production alongside North America.
Robust Regulatory Framework :
Europe's stringent regulatory standards and established pharmaceutical infrastructure provide a competitive advantage, with EMA approval pathways and GMP compliance driving investment in advanced mRNA manufacturing facilities across the region.
Steady Growth Trajectory :
The European market is projected to reach $445.49 million by 2029, growing at a CAGR of 4.4%, reflecting sustained demand for mRNA-based therapeutics and vaccines driven by ongoing clinical development and commercialization efforts.
Germany's Market Dominance :
Germany leads European mRNA manufacturing with a market size of $164.1 million, followed by the UK at $108.2 million and France at $68.52 million, reflecting strong biotech ecosystems and manufacturing capabilities across these nations.
Europe mRNA Synthesis & Manufacturing Market Dynamics
- The region benefits from established regulatory frameworks, skilled workforce availability, and strategic government initiatives promoting biotechnology innovation.
- Key European markets including Germany, UK, and France are driving technological advancement and manufacturing capacity expansion. The market outlook remains positive as European manufacturers scale production capabilities to meet global demand for mRNA vaccines and therapeutics.
- Collaborations between academic institutions, biotech companies, and pharmaceutical giants are accelerating innovation and commercialization.
- Continued investment in manufacturing infrastructure and regulatory harmonization across EU member states will further strengthen Europe's position as a leading mRNA production hub through the forecast period..
Related Ecosystem
Advanced Genetic Sequencing
- Polymerase Chain Reaction (PCR)
- Reagents
- Assay Kits
- Bioinformatics
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- Agilent Technologies, Inc.
- Qiagen N.V.
- Danaher Corporation
Analytical And Scientific Instrumentation
- Environmental Testing
- Gas Chromatography
- Polymerase Chain Reaction (PCR)
- Automated Liquid Handling Systems
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Agilent Technologies, Inc.
- Shimadzu Corporation
- Merck KGaA
Pharmaceuticals
- Bioreactors
- Analytical Testing
- Bioanalytical Testing Services
- Cell Counters
- Data Management Services
- Thermo Fisher Scientific Inc.
- SANOFI
- Merck KGaA
- NOVARTIS
- Pfizer Inc.
Key Takeaways
- Europe's mRNA synthesis and manufacturing market is valued at $359.36 million in 2024 and will reach $445.49 million by 2029, growing at 4.4% CAGR.
- Europe benefits from robust regulatory support, advanced pharmaceutical infrastructure, and strong government backing for mRNA technology development and production.
- Key European markets including Germany, Switzerland, and the UK are leading innovation in mRNA synthesis platforms and contract manufacturing services.
- Europe's emphasis on supply chain resilience and domestic manufacturing capacity positions the region as a strategic player in global mRNA production.
mRNA Synthesis & Manufacturing Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | MRNA SYNTHESIS & MODIFICATION SERVICES (Service) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 5.8% from 2024 to 2029 |
| Largest Segment | CONSUMABLES (Product) |
| Market Size Base Year (Billions) | ~USD 2.23 (2024) |
| Revenue Forecast (Billions) | ~USD 2.96 (2029) |
| Segments Covered | Product, Type, Application, End User, Service, Consumables, Transcription Consumables, Purification Consumables, Analysis & Characterization Consumables |
Europe mRNA Synthesis & Manufacturing Market Report Segmentation
9 segment dimensions are covered across the global market.
By Product
- Consumables
- Instruments
By Type
- Analysis & Characterization Consumables
- Analysis Kits And Reagents
- Chromatography Filters & Membrane
- Mrna Profiling Kits
- Mrna Synthesis Kits
- Nucleotides
- Other Products
- Other Purification Consumables
- Other Transcription Consumables
- Plasmid Dna/Dna Templates
- Purification Consumables
- Purification Kits & Reagents
- Rna Polymerases
- Transcription Consumables
- Vectors
By Application
- Cell & Gene Therapies
- Other Applications
- Vaccines
By End User
- Academic & Research Institutions
- Cros & Cdmos
- Cros And Cdmos
- Pharmaceutical & Biotechnology Companies
- Small-Scale Cros & Cdmos
By Service
- Manufacturing & Scale-Up Services
- Mrna Analysis & Characterization Services
- Mrna Purification Services
- Mrna Synthesis & Modification Services
By Consumables
- Analysis & Characterization Consumables
- Purification Consumables
- Transcription Consumables
By Transcription Consumables
- Mrna Profiling Kits
- Mrna Synthesis Kits
- Nucleotides
- Other Transcription Consumables
- Plasmid Dna/Dna Templates
- Rna Polymerases
- Vectors
By Purification Consumables
- Chromatography Filters & Membranes
- Other Purification Consumables
- Purification Kits & Reagents
- Purification Kits And Reagents
By Analysis & Characterization Consumables
- Analysis Kits & Reagents
- Analysis Kits And Reagents
- Other Analysis & Characterization Consumables
REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTIONS | 11.8 | 10.1 | 9.9 | 10.2 | 10.6 | 11.2 | 11.8 | 12.7 | 5.1 |
| PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES | 33.6 | 28.7 | 28.5 | 29.3 | 30.7 | 32.4 | 34.4 | 37.2 | 5.5 |
| SMALL-SCALE CROS & CDMOS | 4 | 3.4 | 3.3 | 3.4 | 3.5 | 3.6 | 3.8 | 4.1 | 4.2 |
| TOTAL | 49.4 | 42.1 | 41.8 | 42.9 | 44.9 | 47.2 | 50 | 54 | 5.3 |
EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTIONS | 129.6 | 94.6 | 94.7 | 97.6 | 101.9 | 106.5 | 111.2 | 117.6 | 4.4 |
| CROS & CDMOS | 110.8 | 80.8 | 80.8 | 83.3 | 86.9 | 90.7 | 94.6 | 100 | 4.3 |
| PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES | 306.2 | 223.7 | 224.5 | 231.8 | 242.5 | 253.7 | 265.4 | 281.2 | 4.6 |
| TOTAL | 546.7 | 399 | 400.1 | 412.7 | 431.3 | 450.8 | 471.1 | 498.7 | 4.5 |
Target Audience
- Pharmaceutical & Biotech Companies : Manufacturers and developers seeking to establish or expand mRNA production capabilities in Europe need regional market data to identify optimal locations, assess competitive dynamics, and plan manufacturing investments.
- Contract Manufacturing Organizations (CMOs) : CMOs operating in Europe require detailed market insights to understand demand forecasts, capacity requirements, and competitive positioning to secure contracts and optimize service offerings.
- Investment & Private Equity Firms : Investors evaluating opportunities in European mRNA manufacturing need comprehensive market analysis, growth projections, and regional dynamics to identify high-potential acquisition and investment targets.
- Government & Regulatory Bodies : European policymakers and regulatory agencies use market intelligence to inform biotech policy, manufacturing incentives, and infrastructure development strategies supporting regional competitiveness.
- Supply Chain & Equipment Providers : Suppliers of mRNA synthesis equipment, raw materials, and manufacturing solutions need market forecasts and regional demand data to align product development and sales strategies with European market growth.
Countries within Europe - compare and drill down
| Country | 2025 size (native) |
|---|---|
| Germany | USD 164.1 Million |
| UK | USD 108.2 Million |
| France | USD 68.52 Million |
| Switzerland | USD 36.54 Million |
| Italy | USD 16.63 Million |
| Spain | USD 14.62 Million |
| Rest Of Europe | USD 65 Million |
Country market size visualization
Reasons to Buy this Report
- Regional Market Segmentation : Gain detailed insights into Europe's mRNA market dynamics, including country-level breakdowns for Germany, UK, France, Switzerland, Italy, and Spain, enabling targeted market entry and expansion strategies.
- Competitive Landscape Analysis : Understand the competitive positioning of European mRNA manufacturers, regulatory requirements, and manufacturing capabilities to identify partnership and investment opportunities across the region.
- Growth Forecasting & Trends : Access comprehensive 5-year forecasts (2024-2029) with 4.4% CAGR projections, identifying emerging opportunities in mRNA synthesis, manufacturing scale-up, and therapeutic development in Europe.
- Regulatory & Infrastructure Insights : Leverage detailed analysis of European regulatory frameworks, GMP compliance standards, and manufacturing infrastructure to navigate market entry and operational planning effectively.
- Strategic Decision Support : Make informed investment, partnership, and expansion decisions with data-driven insights on European market potential, key growth drivers, and regional market dynamics through 2029.
Frequently asked questions
What is the current market size of mRNA synthesis and manufacturing in Europe?
Europe's mRNA synthesis and manufacturing market was valued at $359.36 million in 2024 and is expected to grow to $445.49 million by 2029.
What is the projected growth rate for Europe's mRNA market through 2029?
Europe's mRNA synthesis and manufacturing market is projected to grow at a compound annual growth rate (CAGR) of 4.4% from 2024 to 2029.
Which European countries are leading the mRNA synthesis and manufacturing market?
Germany, Switzerland, and the United Kingdom are among the key European markets driving innovation and growth in mRNA synthesis platforms and contract manufacturing services.
What factors are driving growth in Europe's mRNA market?
Growth in Europe is driven by strong regulatory frameworks, increased healthcare expenditures, government support for biopharmaceutical manufacturing, expanding vaccine production capacity, and growing clinical applications of mRNA therapeutics.
How does Europe's regulatory environment support mRNA market development?
Europe's regulatory bodies, particularly the European Medicines Agency (EMA), have implemented streamlined approval pathways for mRNA products, accelerating market entry and commercialization of mRNA-based therapeutics and vaccines.
RESEARCH METHODOLOGY
The study involved major activities in estimating the current market size for the mRNA synthesis and manufacturing market. Exhaustive secondary research was done to collect information on the mRNA synthesis and manufacturing industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as market share analysis, MnM repository analysis, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the mRNA synthesis and manufacturing market.
Secondary Research
The market for the companies offering mRNA synthesis and manufacturing solutions is arrived at by secondary data available through paid and unpaid sources, analyzing the product & service portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various sources were referred to in the secondary research process to identify and collect information for this study. The secondary sources include annual reports, press releases, investor presentations of companies, white papers, journals, certified publications, and articles from recognized authors, directories, and databases. In the secondary research process, various secondary sources were referred to for identifying and collecting information related to the study. Secondary sources included annual reports, press releases, and investor presentations of blockchain vendors, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and product-oriented perspectives.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global mRNA synthesis and manufacturing market scenario. Several primary interviews were conducted with market experts from both the demand side (such as personnel from the pharmaceutical & biopharmaceutical industry) and the supply side (such as C-level and D-level executives, product managers, marketing and sales managers of key manufacturers, distributors, as well as channels) across five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. Approximately 80% and 20% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, and online, personal, and telephonic interviews.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Top-down approache was used to estimate and validate the total size of the mRNA synthesis and manufacturing market. These methods include market share analysis, MnM repository analysis were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and market have been identified through extensive secondary research.
- The revenues generated from the mRNA synthesis and manufacturing market business of leading players have been determined through primary and secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.
Market Definition
mRNA synthesis and manufacturing refers to the process of producing messenger RNA (mRNA) through in vitro transcription, followed by various purification, and characterization steps to create high-quality mRNA products suitable for research, therapeutic, or vaccine applications. The mRNA synthesis and manufacturing market encompasses the development, production, and commercialization of messenger RNA (mRNA) products, including their synthesis via in vitro transcription, large-scale manufacturing, and formulation. This market serves various applications such as vaccines, therapeutic treatments, and potentially other areas like protein replacement. It involves specialized technologies and equipment, adherence to regulatory standards, and a global supply chain network.
The study provides an in-depth analysis of the mRNA synthesis and manufacturing market based on contemporary market trends and developments, and its potential growth from 2024 to 2029. It includes detailed market trends, the competitive landscape, market size, forecasts, and the analysis of the key mRNA synthesis and manufacturing product and service providers.
Stakeholders
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Development and Manufacturing Organizations (CDMOs)
- Raw Material Suppliers
- Market Research and Consulting Firms
- Regulatory Agencies
- Venture Capitalists
- Government Organizations
- Industry Associations and Professional Societies
Report Objectives
- To define, describe, and forecast the mRNA synthesis and manufacturing market based on product, service, application, and region
- To define, describe, and forecast the mRNA synthesis and manufacturing market based on product by end user and service by end user
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the mRNA synthesis and manufacturing market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To profile the key players in the global mRNA synthesis and manufacturing market and comprehensively analyze their products and services portfolios, market positions, and core competencies.
- To track and analyze competitive developments such as product/service launches, expansions, agreements, and collaborations in the mRNA synthesis and manufacturing market
- To benchmark players within the mRNA synthesis and manufacturing market using the Company Evaluation Matrix framework, which analyzes market players based on various parameters within the broad categories of business and service strategy
Get the Full mRNA Synthesis & Manufacturing Market Report
Full forecast, segment splits, and company analysis for all mRNA Synthesis & Manufacturing Market.
- Canada mRNA Synthesis & Manufacturing Market
- US mRNA Synthesis & Manufacturing Market
- Germany mRNA Synthesis & Manufacturing Market
- UK mRNA Synthesis & Manufacturing Market
- France mRNA Synthesis & Manufacturing Market
- Switzerland mRNA Synthesis & Manufacturing Market
- Italy mRNA Synthesis & Manufacturing Market
- Spain mRNA Synthesis & Manufacturing Market
- China mRNA Synthesis & Manufacturing Market
- Japan mRNA Synthesis & Manufacturing Market
- India mRNA Synthesis & Manufacturing Market
- South Korea mRNA Synthesis & Manufacturing Market
- Brazil mRNA Synthesis & Manufacturing Market
- Rest Of Europe mRNA Synthesis & Manufacturing Market
- Rest Of Asia Pacific mRNA Synthesis & Manufacturing Market
- Rest Of Latin America mRNA Synthesis & Manufacturing Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
